PetMed Express Cash Flow Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Year	2023	2022	2021	2020	2019	2018 - 1996
Net Income	-7.46	5.14	18.72	23.92	25.85	Upgrade
Depreciation & Amortization	7.06	3.55	2.74	2.43	2.26	Upgrade
Share-Based Compensation	6.87	6.62	4.55	3.31	2.82	Upgrade
Other Operating Activities	-2.14	12.5	-7.51	10.42	7.91	Upgrade
Operating Cash Flow	4.32	27.8	18.5	40.08	38.84	Upgrade
Operating Cash Flow Growth	-84.47%	50.30%	-53.84%	3.17%	-13.94%	Upgrade
Capital Expenditures	-4.51	-5.26	-1.75	-2.43	-2.31	Upgrade
Acquisitions	-36.16	-5	0	0	0	Upgrade
Investing Cash Flow	-40.67	-10.26	-1.75	-2.43	-2.31	Upgrade
Dividends Paid	-12.44	-24.54	-24.38	-22.69	-21.8	Upgrade
Share Issuance / Repurchase	0	0	0	0	-11.5	Upgrade
Financing Cash Flow	-12.44	-24.54	-24.38	-22.69	-33.3	Upgrade
Net Cash Flow	-48.79	-6.99	-7.64	14.96	3.23	Upgrade
Free Cash Flow	-0.19	22.54	16.75	37.64	36.53	Upgrade
Free Cash Flow Growth	-	34.62%	-55.51%	3.04%	-17.94%	Upgrade
Free Cash Flow Margin	-0.07%	8.79%	6.15%	12.40%	12.86%	Upgrade
Free Cash Flow Per Share	-0.01	1.11	0.83	1.88	1.82	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).